BHLHE22-AS1: A Potential Drug Target and Biomarker (G401463)

Target Name: BHLHE22-AS1

NCBI ID: G401463

Other Name(s): BHLHE22-AS1 variant 1 | BHLHE22 antisense RNA 1 | BHLHE22 antisense RNA 1, transcript variant 1

BHLHE22-AS1: A Potential Drug Target and Biomarker

BHLHE22-AS1, also known as BHLHE22-AS1 variant 1, is a gene that encodes a protein known as BHLHE22. This protein is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues such as blood vessels , neural tubes, and epithelial cells. BHLHE22 has also been shown to play a role in the regulation of cancer growth and progression.

Recent studies have identified BHLHE22 as a potential drug target due to its involvement in various cellular processes that are associated with cancer. For example, BHLHE22 has been shown to promote the growth and survival of various cancer cell types, including breast, ovarian, and prostate Cancer cells. Additionally, BHLHE22 has been shown to play a role in the development of cancer stem cells, which are capable of self-replicating and promoting the growth of cancer.

In addition to its potential as a drug target, BHLHE22 has also been identified as a potential biomarker for cancer. The expression of BHLHE22 has been shown to be upregulated in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, BHLHE22 has been shown to be downregulated in various normal tissues, such as blood vessels and epithelial cells. This suggests that BHLHE22 may be a useful biomarker for the diagnosis and prognosis of cancer.

The identification of BHLHE22 as a potential drug target and biomarker has significant implications for the development of new cancer therapies. By targeting BHLHE22, researchers may be able to inhibit its function and reduce the growth and spread of cancer cells. Additionally, the development of BHLHE22 as a biomarker may help researchers to diagnose and monitor the effectiveness of existing cancer therapies.

In conclusion, BHLHE22-AS1 is a gene that encodes a protein involved in the regulation of cell growth and differentiation. Recent studies have identified BHLHE22 as a potential drug target and biomarker for cancer. Further research is needed to fully understand the role of BHLHE22 in cancer biology and to develop new cancer therapies.

Protein Name: BHLHE22 Antisense RNA 1

More Common Targets